Company intelligence / Profile preview

J3 Biosciences

Salt Lake City, Utah, United Statesj3bio.com ↗

Ownership: Private
Employees: ~8
Development stage: Commercial

Overview

J3 Bioscience has developed the LivRing®, an FDA-cleared, patented intravaginal ring that provides long-lasting controlled-release moisturizing lubrication for up to seven days. It addresses chronic vaginal dryness in post-menopausal and pre-menopausal women. The LivRing® is hormone-free, fragrance-free, self-inserted/removed weekly, and available over-the-counter. Clinical feedback highlights its effectiveness in improving comfort during sexual activity.

Therapeutic areas: Women's Health
Modalities: DeviceIntravaginal ring (IVR)Non-pharmacological therapy
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

LivRing

Commercial

Indications: Vaginal dryness

Beyond the preview

Go deeper on J3 Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on J3 Biosciences.

Explore the full profile